Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectivity and Safety of Combination Cream of Salicylic Acid, Aqua Posae Filiformis, Niacinamide, Lipohydroxy Acid, Procerad and Zinc PCA as Adjuvant Therapy for Acne Vulgaris Mild to Moderate

NCT05497323 is registered in ClinicalTrials.gov with Dr.dr.Irma Bernadette, SpKK (K) as lead sponsor.

NCT NCT05497323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05497323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectivity and Safety of Combination Cream of Salicylic Acid, Aqua Posae Filiformis, Niacinamide, Lipohydroxy Acid, Procerad and Zinc PCA as Adjuvant Therapy for Acne Vulgaris Mild to Moderate
Lead sponsor
Dr.dr.Irma Bernadette, SpKK (K)
Phase
Phase 1
Overall status
Unknown status
Start date
August 1, 2022
Completion date
May 1, 2023
Enrollment
284 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris